Search
Aardvark Therapeutics Inc
AARDAdd to Watchlist
5.510USD
-0.050-0.90%
Market hours 09/24, 15:17（ET）
120.56MMarket Cap
LossP/E TTM
AARD Financials
See Aardvark Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
120.56M
Dividend TTM
0.00
P/E TTM
-1.71
EPS TTM
-3.22
Revenue
--
Net Profit
-20.59M
ROE
-58.79%
ROA
-54.67%
Aardvark Therapeutics Inc Earnings Date
Latest Release
Aug 11, 2026
EPS / Forecast
-0.66/-0.87
Revenue / Forecast
--/0.00
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its current assets were 111.89M, with a year-on-year change of 50.92.
What are the total assets of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its total assets of Aardvark Therapeutics Inc were 117.18M, with a year-on-year change of 51.19.
What are the total liabilities of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its total liabilities of Aardvark Therapeutics Inc were 10.55M, with a year-on-year change of 95.55.
What is the total equity of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its total equity of Aardvark Therapeutics Inc was 106.63M, with a year-on-year change of 47.87.
What is the net operating income of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its net operating income of Aardvark Therapeutics Inc was -62.73M, with a year-on-year change of -175.29.
What is the net investment of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its net investment of Aardvark Therapeutics Inc was -49.67M, with a year-on-year change of -313.96.
What is the net financing of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its net financing of Aardvark Therapeutics Inc was 89.25M, with a year-on-year change of 8.85.
What is the Earnings Per Share (EPS) of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.93, with a year-on-year change of -204.81.
What is the net income of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its net income was -57.59M, with a year-on-year change of -179.73.
What is the Return on Assets (ROA) of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -59.16, with a year-on-year change of -26.50.
What is the operating profit of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its operating profit was -62.73M, with a year-on-year change of -175.29.